{"id":"W2584246182","doi":"10.1182/blood.v128.22.1108.1108","title":"Pembrolizumab in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Long-Term Efficacy from the Phase 1b Keynote-013 Study","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Brentuximab vedotin; Pembrolizumab; Medicine; Oncology; Internal medicine; Cohort; Transplantation; Phases of clinical research; Autologous stem-cell transplantation; Lymphoma; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003424603,0.0008028349,0.001231671,0.0002459722,0.0003994636,0.001088743,0.0006398106,0.0008434092,0.001572289],"category_scores_gemma":[0.001366696,0.0003648076,0.001254263,0.0005338943,0.0004182457,0.0009138537,0.0005368635,0.001741287,0.0004669591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008225093,"about_ca_system_score_gemma":0.0009958821,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005817857,"about_ca_topic_score_gemma":0.001125641,"domain_scores_codex":[0.999319,0.0003247193,0.00005743434,0.0001231037,0.00007694158,0.0000988498],"domain_scores_gemma":[0.9989179,0.0001915114,0.0002789077,0.000131921,0.0001085658,0.0003711447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6978143,0.0132735,0.1015073,0.001837792,0.00748825,0.0007711818,0.0004588271,0.003091071,0.02798972,0.0002974559,0.008687631,0.136783],"study_design_scores_gemma":[0.4541472,0.2153644,0.3031123,0.0003089056,0.005758678,0.001420454,0.0002434415,0.001986174,0.005128956,0.0004366235,0.01199139,0.0001013653],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897258,0.005290319,0.0004141585,0.0003035037,0.00005773161,0.0007365766,0.002192909,0.00003923169,0.001239831],"genre_scores_gemma":[0.9919743,0.001482246,0.0004447661,0.0006312125,0.0001017269,0.0006022672,0.004232263,0.00001147258,0.0005198381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003424603,"threshold_uncertainty_score":0.01811123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007994738585659232,"score_gpt":0.2436282702871269,"score_spread":0.2356335317014677,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}